GO:0031998 regulation of fatty acid beta-oxidation: Metabolic Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031998 (regulation of fatty acid beta-oxidation) describes any biological process that modulates the frequency, rate, or extent of fatty acid beta-oxidation, the mitochondrial and peroxisomal catabolic pathway that shortens fatty acyl chains to generate acetyl-CoA and reducing equivalents.
• The pathway is controlled at multiple levels, including transcriptional regulation by PPARalpha and PGC-1alpha, post-translational modification of enzymes, substrate availability, and mitochondrial permeability.
• Dysregulation of fatty acid beta-oxidation is linked to metabolic dysfunction-associated steatotic liver disease (MASLD), non-alcoholic steatohepatitis (NASH), cardiac disease, and cancer stem cell chemoresistance.
• Key regulatory nodes include PPARalpha, PGC-1alpha, SIRT1, FABP5, JAK/STAT3, and pSTAT4-OX40 signaling, which integrate nutrient and stress signals into beta-oxidation flux.
• Experimental dissection of GO:0031998 requires combining metabolic flux assays, transcriptomics, proteomics, and CRISPR-based perturbation of candidate regulators.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening with bioinformatics to causally test regulators of fatty acid beta-oxidation.
Description
Fatty acid beta-oxidation is the central catabolic process by which cells break down fatty acids to produce acetyl-CoA, NADH, and FADH2, fueling the tricarboxylic acid cycle and oxidative phosphorylation. The Gene Ontology term GO:0031998, regulation of fatty acid beta-oxidation, captures the diverse mechanisms that adjust the rate of this pathway in response to nutritional, hormonal, and stress signals. Because fatty acid oxidation is essential for energy homeostasis in tissues such as liver, heart, and skeletal muscle, its regulatory control has broad physiological and pathological significance. At the molecular level, regulation of fatty acid beta-oxidation involves transcriptional programs driven by nuclear receptors such as PPARalpha, coactivators like PGC-1alpha, and signaling cascades including JAK/STAT3 and pSTAT4-OX40. Post-transcriptional and post-translational mechanisms, as well as mitochondrial substrate access and permeability, further tune flux through the pathway. These layers of control ensure that beta-oxidation matches cellular energy demand and avoids lipotoxic accumulation of fatty acids. For researchers, GO:0031998 provides a conceptual framework to study how genetic and pharmacological perturbations alter fatty acid catabolism in diseases such as MASLD, NASH, heart failure, and cancer. Understanding these regulatory nodes can reveal therapeutic targets and biomarkers, and it requires robust experimental models that can distinguish causal regulators from correlative changes.
regulation of fatty acid beta-oxidation At A Glance
| GO ID | GO:0031998 |
|---|---|
| GO term | regulation of fatty acid beta-oxidation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the rate, frequency, or extent of fatty acid beta-oxidation, the catabolic pathway that shortens fatty acyl chains to generate acetyl-CoA and reducing equivalents. |
| Subcellular locations | Mitochondria and peroxisomes are the principal sites of fatty acid beta-oxidation in eukaryotic cells. |
| Key regulators | PPARalpha, PGC-1alpha, SIRT1, FABP5, JAK/STAT3, and pSTAT4-OX40 signaling are among the pathways that regulate beta-oxidation. |
| Physiological context | Energy homeostasis in liver, heart, skeletal muscle, and immune cells depends on appropriate regulation of fatty acid beta-oxidation. |
| Disease relevance | Altered regulation of beta-oxidation contributes to MASLD, NASH, cardiac dysfunction, and cancer stem cell chemoresistance. |
What Is GO:0031998?
GO:0031998, regulation of fatty acid beta-oxidation, is a biological process term defined as any process that modulates the frequency, rate, or extent of fatty acid beta-oxidation. In practice, this includes transcriptional, post-transcriptional, and signaling events that increase or decrease the breakdown of fatty acids in mitochondria and peroxisomes.
Why Is regulation of fatty acid beta-oxidation Important in Cell Biology?
Regulation of fatty acid beta-oxidation is critical because it determines whether cells burn or store fat, directly influencing energy balance, lipotoxicity, and metabolic signaling. Dysregulation of this process is a hallmark of metabolic diseases such as MASLD and NASH, and it also affects cardiac function and cancer cell survival. Understanding GO:0031998 therefore has direct implications for identifying therapeutic targets and for interpreting metabolic phenotypes in genetic and pharmacological studies.
• Maintains energy homeostasis by matching fatty acid oxidation rates to cellular ATP demand.
• Prevents lipotoxicity by clearing excess fatty acids through beta-oxidation.
• Is dysregulated in metabolic dysfunction-associated steatotic liver disease (MASLD) and non-alcoholic steatohepatitis (NASH).
• Supports cardiac function, where fatty acid oxidation provides a major portion of ATP in the healthy heart.
• Promotes cancer stem cell self-renewal and chemoresistance in breast cancer through JAK/STAT3-regulated beta-oxidation.
• Modulates immune regulatory function of double-negative T cells via pSTAT4-OX40 signaling.
• Is inhibited by stress granules through modulation of mitochondrial permeability.
• Serves as a target of PPARalpha and PGC-1alpha signaling in response to nutritional and hormonal cues.
• Can be regulated by lipid-binding proteins such as FABP5 and circulating factors like asprosin.
• Provides a mechanistic link between lipid metabolism and gene regulation in health and disease.
What Happens During regulation of fatty acid beta-oxidation?
Transcriptional control by nuclear receptors and coactivators
In simple terms: The cell decides how many beta-oxidation enzymes to make by turning genes on or off.
A major layer of regulation of fatty acid beta-oxidation occurs at the transcriptional level, where nuclear receptors such as PPARalpha and coactivators like PGC-1alpha drive expression of genes encoding beta-oxidation enzymes and associated proteins. PPARalpha mediates peroxisomal and mitochondrial fatty acid beta-oxidation in response to ligands and nutritional status. In NASH models, activation of the SIRT1/PGC-1alpha/PPARalpha pathway promotes fatty acid beta-oxidation and improves steatosis. This transcriptional program ensures that the capacity for beta-oxidation matches the availability of fatty acids and the energy needs of the cell.
Signaling pathways that tune beta-oxidation flux
In simple terms: Signals from outside the cell can speed up or slow down fat burning.
Cytokine and growth factor signaling pathways regulate fatty acid beta-oxidation. JAK/STAT3 signaling is critical for breast cancer stem cell self-renewal and chemoresistance by regulating fatty acid beta-oxidation. In double-negative T cells, pSTAT4-OX40 signaling enhances immune regulatory function through fatty acid beta-oxidation. These pathways integrate immune and metabolic cues to adjust beta-oxidation rates in specific cell types.
Substrate availability and lipid-binding proteins
In simple terms: How much fat is available and how it is transported affects how fast it is burned.
The rate of fatty acid beta-oxidation depends on the delivery of fatty acids to mitochondria and peroxisomes. Long-chain fatty acids themselves can regulate energy metabolism and gene expression. The lipid-binding protein FABP5 interacts with asprosin to modulate mitochondrial fatty acid oxidation through PPARalpha, contributing to MASLD development. Thus, substrate supply and intracellular transport are key determinants of beta-oxidation flux.
Mitochondrial permeability and stress responses
In simple terms: When cells are stressed, they can shut down fat burning by changing mitochondrial access.
Stress granules inhibit fatty acid oxidation by modulating mitochondrial permeability, providing a rapid mechanism to reduce beta-oxidation under stress. This regulation links cellular stress responses to metabolic remodeling and may protect cells from oxidative damage during adverse conditions. Mitochondrial permeability therefore acts as a checkpoint for fatty acid beta-oxidation.
Integration with energy metabolism and disease
In simple terms: Fat burning is connected to the heart, liver, and cancer, so its regulation matters for many diseases.
Myocardial fatty acid metabolism is tightly regulated to meet the heart's high energy demand, and its dysregulation contributes to cardiac disease. In the liver, impaired regulation of beta-oxidation contributes to steatosis and NASH. In cancer, upregulation of beta-oxidation supports stem cell properties and chemoresistance. These examples illustrate how GO:0031998 integrates with diverse physiological and pathological processes.
Key Genes Involved in GO:0031998 regulation of fatty acid beta-oxidation
The following genes and proteins are experimentally implicated in the regulation of fatty acid beta-oxidation and represent high-value targets for functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPARalpha | Nuclear receptor that transcriptionally activates fatty acid beta-oxidation genes | Central regulator of peroxisomal and mitochondrial beta-oxidation; target in MASLD and NASH |
| PGC-1alpha | Transcriptional coactivator that enhances PPARalpha-driven beta-oxidation programs | Mediates SIRT1-dependent promotion of beta-oxidation in NASH models |
| SIRT1 | Deacetylase that activates PGC-1alpha and supports beta-oxidation | Upstream regulator in the SIRT1/PGC-1alpha/PPARalpha pathway |
| FABP5 | Lipid-binding protein that modulates mitochondrial fatty acid oxidation | Interacts with asprosin to regulate PPARalpha and MASLD development |
| JAK | Kinase that activates STAT3 signaling | Regulates fatty acid beta-oxidation in breast cancer stem cells |
| STAT3 | Transcription factor downstream of JAK | Critical for beta-oxidation-mediated stem cell self-renewal and chemoresistance |
| STAT4 | Transcription factor activated by cytokines | Part of pSTAT4-OX40 signaling that enhances beta-oxidation in double-negative T cells |
| OX40 | Costimulatory receptor that activates pSTAT4 signaling | Links immune signaling to fatty acid beta-oxidation in T cells |
| CPT1A | Rate-limiting enzyme for mitochondrial long-chain fatty acid entry | Target for modulating beta-oxidation flux in metabolic studies |
| ACOX1 | Peroxisomal acyl-CoA oxidase | Key enzyme in peroxisomal beta-oxidation regulated by PPARalpha |
| HADHA | Mitochondrial trifunctional protein subunit | Catalyzes steps in mitochondrial beta-oxidation; relevant to energy metabolism |
| ACADM | Medium-chain acyl-CoA dehydrogenase | Mitochondrial beta-oxidation enzyme; model for flux studies |
| UCP2 | Mitochondrial uncoupling protein | Modulates mitochondrial permeability and beta-oxidation |
| VDAC | Voltage-dependent anion channel | Involved in mitochondrial permeability regulation of beta-oxidation |
| Asprosin | Circulating hormone that interacts with FABP5 | Modulates mitochondrial fatty acid oxidation via PPARalpha in MASLD |
| Formononetin | Natural compound that promotes beta-oxidation | Activates SIRT1/PGC-1alpha/PPARalpha to treat NASH |
| Long-chain fatty acids | Substrates and signaling molecules | Regulate energy metabolism and beta-oxidation gene expression |
| pSTAT4 | Phosphorylated STAT4 | Mediates OX40 signaling to enhance beta-oxidation in T cells |
How Is regulation of fatty acid beta-oxidation Regulated?
Regulation of fatty acid beta-oxidation is achieved through multiple interconnected mechanisms. Transcriptional control by PPARalpha and PGC-1alpha sets the capacity of the pathway, while SIRT1-dependent deacetylation activates PGC-1alpha in response to metabolic stress. Cytokine signaling through JAK/STAT3 and pSTAT4-OX40 adjusts beta-oxidation in cancer stem cells and immune cells, respectively. Substrate availability and lipid-binding proteins such as FABP5, as well as circulating factors like asprosin, modulate flux through PPARalpha-dependent pathways. Finally, stress granules can acutely inhibit beta-oxidation by altering mitochondrial permeability. Together, these layers ensure that fatty acid oxidation is matched to cellular energy demand and stress conditions.
regulation of fatty acid beta-oxidation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PPARalpha | MASLD, NASH, peroxisomal beta-oxidation disorders | Knockout or overexpression in hepatocytes; PPARalpha agonist treatment |
| SIRT1 | NASH, metabolic stress | SIRT1 knockout or overexpression with formononetin treatment |
| FABP5 | MASLD, lipid handling | FABP5 knockout or knock-in in liver cell lines; asprosin treatment |
| STAT3 | Breast cancer stem cell chemoresistance | STAT3 knockout or point mutation in breast cancer stem cell models |
| STAT4/OX40 | Immune regulation in double-negative T cells | STAT4 knockout or OX40 stimulation in T cell cultures |
Metabolic dysfunction-associated steatotic liver disease (MASLD) and NASH
Impaired regulation of fatty acid beta-oxidation contributes to hepatic lipid accumulation and steatohepatitis. Activation of the SIRT1/PGC-1alpha/PPARalpha pathway by formononetin promotes beta-oxidation and treats NASH in experimental models. Asprosin-FABP5 interaction modulates mitochondrial fatty acid oxidation through PPARalpha and contributes to MASLD development. These findings highlight beta-oxidation regulators as therapeutic targets in fatty liver diseases.
Cardiac disease
The heart relies heavily on fatty acid beta-oxidation for ATP production, and dysregulation of this pathway is implicated in heart failure and ischemic injury. Myocardial fatty acid metabolism in health and disease is a well-established area where regulatory mechanisms determine cardiac energetics and function. Targeting beta-oxidation regulators may offer cardioprotective strategies.
Cancer stem cell chemoresistance
JAK/STAT3-regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Inhibiting beta-oxidation or its upstream regulators may sensitize cancer stem cells to chemotherapy. This links GO:0031998 to oncology and suggests metabolic vulnerabilities in cancer.
Immune regulation
Fatty acid beta-oxidation enhances the immune regulatory function of double-negative T cells through pSTAT4-OX40 signaling. This indicates that beta-oxidation regulation can shape immune responses and may be relevant to autoimmune and inflammatory conditions.
From regulation of fatty acid beta-oxidation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PPARalpha reduce beta-oxidation capacity? | PPARalpha knockout cell line or hepatocyte-specific knockout |
| Does a point mutation in STAT3 affect beta-oxidation and chemoresistance? | STAT3 point-mutation knock-in in breast cancer cells |
| Does overexpression of PGC-1alpha enhance beta-oxidation? | PGC-1alpha overexpression cell model |
| Does FABP5 interaction with asprosin modulate mitochondrial beta-oxidation? | FABP5 knockout or tagged knock-in for interaction studies |
| Does OX40 signaling require STAT4 for beta-oxidation enhancement? | STAT4 knockout or phospho-mutant knock-in in T cells |
| Can stress granules inhibit beta-oxidation via mitochondrial permeability? | UCP2 or VDAC knockout/overexpression models |
How to Study the regulation of fatty acid beta-oxidation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled fatty acid oxidation assay | Rate of beta-oxidation flux | Quantifying pathway activity in cells or mitochondria |
| RNA-seq | Transcriptional changes in beta-oxidation genes | Identifying PPARalpha/PGC-1alpha target programs |
| Proteomics | Protein abundance and modifications | Detecting post-translational regulation of beta-oxidation enzymes |
| Seahorse respirometry | Mitochondrial oxygen consumption | Assessing fatty acid-dependent respiration |
| Live-cell imaging | Mitochondrial permeability and lipid dynamics | Studying stress granule effects on beta-oxidation |
| CRISPR knockout screening | Gene requirement for beta-oxidation | Identifying novel regulators of GO:0031998 |
| CRISPR point-mutation knock-in | Effect of specific amino acid changes | Testing phospho-mutant STAT3 or STAT4 |
| Overexpression models | Gain-of-function effects | Testing PGC-1alpha or FABP5 sufficiency |
Metabolic flux assays
Measuring fatty acid beta-oxidation flux is essential to determine whether a regulator causally changes pathway activity. Radiolabeled or fluorescent fatty acid oxidation assays in live cells or isolated mitochondria can quantify flux. These assays are typically combined with genetic perturbation to link specific genes to GO:0031998.
Transcriptomics and proteomics
RNA-seq and proteomics can identify changes in beta-oxidation gene expression programs following perturbation of candidate regulators such as PPARalpha or PGC-1alpha. These approaches reveal whether regulation occurs at the transcriptional level and which downstream enzymes are affected.
Imaging and mitochondrial function
Live-cell imaging with fluorescent fatty acid analogs or mitochondrial membrane potential dyes can assess mitochondrial permeability and beta-oxidation activity. Such methods are useful for studying stress granule-mediated inhibition of beta-oxidation.
CRISPR-based perturbation
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes implicated in regulation of fatty acid beta-oxidation. These models can be combined with metabolic assays to establish directionality and mechanism.
How CRISPR Can Be Used to Study GO:0031998 regulation of fatty acid beta-oxidation
Knockout
CRISPR knockout of candidate regulators such as PPARalpha, SIRT1, or STAT3 can determine whether they are required for fatty acid beta-oxidation. Loss-of-function models combined with metabolic flux assays provide causal evidence for GO:0031998 regulation.
Point Mutation
Point-mutation knock-in can test the importance of specific phosphorylation sites, such as those in STAT3 or STAT4, for beta-oxidation regulation. These models distinguish signaling-dependent regulation from structural roles.
Knock-in
Knock-in of tagged or reporter alleles allows visualization and quantification of beta-oxidation regulators in live cells. Tagged FABP5 or PPARalpha can reveal localization and interaction dynamics relevant to GO:0031998.
Overexpression
Overexpression of PGC-1alpha, FABP5, or constitutively active STAT3 can test sufficiency for enhancing beta-oxidation. These gain-of-function models complement knockout studies to establish bidirectional regulation.
How EDITGENE Supports regulation of fatty acid beta-oxidation Research
Researchers studying regulation of fatty acid beta-oxidation-related genes often need to determine whether a candidate gene is causally involved in modulating pathway flux or is merely correlated with metabolic changes. EDITGENE provides tailored CRISPR cell models and screening services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of fatty acid beta-oxidation research.
Frequently Asked Questions About regulation of fatty acid beta-oxidation
What is GO:0031998 regulation of fatty acid beta-oxidation?
GO:0031998 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of fatty acid beta-oxidation, the catabolic pathway that breaks down fatty acids to generate acetyl-CoA and reducing equivalents.
What genes are involved in regulation of fatty acid beta-oxidation?
Key genes include PPARalpha, PGC-1alpha, SIRT1, FABP5, JAK, STAT3, STAT4, OX40, CPT1A, ACOX1, and HADHA, among others.
How is fatty acid beta-oxidation regulated?
It is regulated at transcriptional, post-transcriptional, and signaling levels, including PPARalpha/PGC-1alpha-driven gene expression, JAK/STAT3 and pSTAT4-OX40 signaling, substrate availability, and mitochondrial permeability.
Why is regulation of fatty acid beta-oxidation important in disease?
Dysregulation contributes to MASLD, NASH, cardiac disease, and cancer stem cell chemoresistance, making it a therapeutic target.
What diseases are linked to fatty acid beta-oxidation dysregulation?
Metabolic dysfunction-associated steatotic liver disease, non-alcoholic steatohepatitis, heart failure, and breast cancer chemoresistance are among the diseases linked to altered beta-oxidation regulation.
How can I study regulation of fatty acid beta-oxidation in the lab?
Combine metabolic flux assays, RNA-seq, proteomics, imaging, and CRISPR-based perturbation of candidate regulators such as PPARalpha or STAT3.
What is the role of PPARalpha in fatty acid beta-oxidation?
PPARalpha is a nuclear receptor that transcriptionally activates genes involved in peroxisomal and mitochondrial fatty acid beta-oxidation.
Does SIRT1 regulate fatty acid beta-oxidation?
Yes, SIRT1 activates PGC-1alpha, which cooperates with PPARalpha to promote fatty acid beta-oxidation in models of NASH.
Can CRISPR be used to study regulation of fatty acid beta-oxidation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes regulating beta-oxidation.
What experimental models are suitable for studying GO:0031998?
Knockout, point-mutation, knock-in, and overexpression cell models, combined with metabolic flux assays and omics, are suitable for studying GO:0031998.
Conclusion
GO:0031998, regulation of fatty acid beta-oxidation, is a central biological process that integrates transcriptional, signaling, and metabolic inputs to control energy homeostasis. Its dysregulation is implicated in major human diseases, including MASLD, NASH, cardiac dysfunction, and cancer chemoresistance. Understanding the causal regulators of this pathway requires robust experimental models and multi-layered assays. EDITGENE supports this research with custom CRISPR cell models, library screening, and bioinformatics to accelerate discovery of therapeutic targets within the regulation of fatty acid beta-oxidation.
References
- 1. Tahri-Joutey M et al.. 2021. Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα.. Int J Mol Sci 22(16) PMID: 34445672
- 2. Nakamura MT et al.. 2014. Regulation of energy metabolism by long-chain fatty acids.. Prog Lipid Res 53:124-44 PMID: 24362249
- 3. Liao J et al.. 2024. Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway.. Phytomedicine 124:155285 PMID: 38185065
- 4. Lopaschuk GD et al.. 2010. Myocardial fatty acid metabolism in health and disease.. Physiol Rev 90(1):207-58 PMID: 20086077
- 5. Amen T et al.. 2021. Stress granules inhibit fatty acid oxidation by modulating mitochondrial permeability.. Cell Rep 35(11):109237 PMID: 34133922
- 6. Wang Z et al.. 2025. Fatty acid β-oxidation enhances immune regulatory function of double-negative T cells through pSTAT4-OX40 signaling pathway.. Hepatol Commun 9(9) PMID: 40879484
- 7. Yu YY et al.. 2025. Asprosin-FABP5 Interaction Modulates Mitochondrial Fatty Acid Oxidation through PPARα Contributing to MASLD Development.. Adv Sci (Weinh) 12(21):e2415846 PMID: 40231957
- 8. Wang T et al.. 2018. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.. Cell Metab 27(1):136-150.e5 PMID: 29249690
